Search Results
477 results
Your search is now limited to «Merck» expert search.
Seeking Alpha 03/22/2019 13:54
After the success of a hedged portfolio built around an AT&T position in 2017, I started presenting similar portfolios built around other conservative stocks, i.
More from Seeking Alpha:
CB Insights - Blog 03/22/2019 12:58
Hi there, Here’s what went down in artificial intelligence this week. Top Deals Enterprise IT UiPath , a robotic process automation startup, reached a $7B valuation with its $400M Series D round, backed by Accel, Credo Ventures, Earlybird Venture Capital, and …. The post This Week In AI: UiPath Raises $400M, Merck Partners With Drug Design Startup, Google Creates First AI-Powered Doodle appeared first on CB Insights Research .
WN.com 03/22/2019 03:17
Merck Foundation awarded the First Lady of Burundi to acknowledge her efforts as “Merck More Than a Mother” Ambassador.
More from WN.com:
Merck Foundation also announces Call for Application for 'Merck More than a Mother' 'Media Recognition Awards' for Burundi and rest of Africa.
More from Middle East North Africa Financial Network (MENAFN):
BioPharma Dive 03/21/2019 11:50
Darmstadt is roughly 20 miles south of Frankfurt and home to multiple science-based organizations beyond Merck, including the European Space Agency's main mission control and an intergovernmental organization focused on operating meteorological satellites.
More from BioPharma Dive:
Zacks.com 03/21/2019 10:10
Merck is collaborating with several companies including Amgen, Incyte, Glaxo and Pfizer separately for the evaluation of Keytruda in combination with other regimens.
More from Zacks.com:
Upon license termination, Merck will grant to NGM an exclusive license under Merck’s intellectual property related to the GDF15 receptor agonist program for further development and commercialization of products, subject to the payment of a low single digit royalty on any future product sales back to Merck ...
More from Pharmaceutical Business Review:
I’m sincerely thankful for Merck’s contribution to my graduate education through its support for higher education and passion for innovation,” said Dr Maria Arendt, 2017 Merck Animal Health PhD fellow.
More from ThePoultrySite - Industry News:
FiercePharmaManufacturing 03/20/2019 11:09
Merck today said that the company management and the Joint Works Council at Darmstadt have signed a comprehensive agreement covering the 11,000 employees to secure its “future viability.
More from FiercePharmaManufacturing:
ENDPOINTS 03/20/2019 10:28
The past four years of collaborating with NGM Bio has delivered a late-stage NASH drug for Merck, which paid up $20 million to license the drug just weeks ago.
More from ENDPOINTS:
FierceBiotech 03/20/2019 09:48
At the annual meeting of the American College of Cardiology this week, a new analysis of data for Merck’s CETP drug anacetrapib cast a shadow on DalCor’s hypothesis.
More from FierceBiotech:
Bionity.com 03/20/2019 08:00
Merck announced the signing of a non-binding Memorandum of Understanding with Chinese biotech company GenScript for a strategic alliance focusing on plasmid and viral vector manufacturing.
More from Bionity.com:
FierceMedicalDevices 03/20/2019 07:53
As Merck boosts R&D pact, NGM Bio gains Genentech, Lilly veteran as new R&D chief.
More from FierceMedicalDevices:
News-Medical.net 03/20/2019 05:51
Mar 20 2019 Merck, a leading science and technology company, today announced the signing of a non-binding Memorandum of Understanding with Chinese biotech company GenScript for a strategic alliance focusing on plasmid and viral vector manufacturing.
More from News-Medical.net:
PR Newswire 03/19/2019 19:15
The global strategic alliance between Merck KGaA, Darmstadt, Germany , and Pfizer enables the companies to benefit from each other's strengths and capabilities and further explore the therapeutic potential of BAVENCIO, an anti-PD-L1 antibody initially discovered and developed by Merck KGaA, Darmstadt, Germany ...
More from PR Newswire:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications